The new CPT code reflects the latest efficacious medical care available to patients, facilitating adoption and utilization.The assignment of a ...

"Publication of the new AMA CPT code represents a significant milestone for Sensydia, and will help foster the adoption of our nninvasive, in-clinic hemodynamic assessment tool by establishing a ...

CVRx, Inc. (NASDAQ: CVRX) ('CVRx”), a commercial-stage medical device company focused on developing, manufacturing and ...

Koelis, SAS ("Koelis" or the "Company", a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer interventions, recently announced that the Centers for Medicare & Medicaid ...

Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and fiscal year ended December 31, 2025. "2025 was ...

Fourth quarter revenue expected to be $15.9 million to $16.1 million, representing growth of 4% to 5%Full year revenue expected to be $56.5 ...

Elucid today announced that, effective January 1, 2026, its Plaque-IQ™ coronary plaque analysis has received a new Category I ...

ASCs remain one of the most efficient sites of care, but growth in 2026 is far from guaranteed. From reimbursement pressure ...

What Is Driving the New Fair Value Estimate for Sight Sciences? Sight Sciences now carries a fair value estimate of US$9.35 ...

Q2 FY2026 earnings call recap: revenue up 8.8%, Auryon & NanoKnife growth, raised guidance, margin outlook and risks—read now.

Elective neurosurgery has quietly crossed a threshold: advances in minimally invasive techniques, anesthesia, and perioperative care have made a set of historically “inpatient” spine and neurovascular ...